首页> 中文期刊> 《中国继续医学教育》 >社区高血压防治与管理路径的探索

社区高血压防治与管理路径的探索

         

摘要

目的:探讨社区高血压防治与管理路径的价值。方法选取200例社区高血压病患作为研究对象,随机分为卡托普利+氯沙坦组和卡托普利组。卡托普利组应用ACEI类药物卡托普利治疗,卡托普利+氯沙坦组应用ACEI类药物卡托普利联合ARB类药物氯沙坦治疗。在药物治疗基础上,均给予护理管理路径,对比两组病患效果。结果(1)卡托普利+氯沙坦组治疗总有效率高于卡托普利组(P<0.05),差异有统计学意义。(2)治疗后卡托普利+氯沙坦组的收缩压和舒张压改善均优于卡托普利组(P<0.05),差异有统计学意义。结论卡托普利和氯沙坦联合治疗高血压的效果良好,同时辅以护理管理路径,有利于改善病患血压情况。%ObjectiveTo investigate the value of community hypertension prevention and management path.Methods200 cases of hypertension patients in community as research subjects were randomly divided into captopril + losartan and captopril group. Captopril group application ACEI drugs captopril, captopril + losartan group application ACEI drugs captopril ARB losartan therapy drugs. In drug treatment, based on nursing management were given path, contrast the two groups of patients.Results (1) captopril + losartan treatment group was significantly higher than the total efficiency of the captopril group (P<0.05), the difference was statistically signiifcant. (2) after treatment with captopril + losartan improve systolic and diastolic blood pressure group were significantly better than captopril group (P<0.05), the difference was statistically significant. ConclusionThe effect of captopril and losartan combined with a good treatment of hypertension, supplemented by nursing management path, improves blood pressure situation, worthy of clinical application.

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号